ISBN: 9783318070101 - Fast Facts: Non-small-cell Lung Cancer (4 results)

ISBN: 
Refine with Advanced Search

Refine your search

  • Books (4)

  • New (4)

to

Custom price range (£)

to

  • Language: English

    Published by S Karger AG, 2022

    3318070106 / 9783318070101

    • Softcover

    Seller: AwesomeBooks, Wallingford, United KingdomAwesomeBooks

    5-star seller
    Contact seller

    Condition: New

    £ 3.86

    £ 4.99 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    paperback. Condition: New. Fast Facts: Non-Small-Cell Lung Cancer Brand new item sourced directly from publisher. Packed securely in tight packaging to ensure no damage. Shipped from warehouse on same/next day basis.

  • Language: English

    Published by S. Karger Karger Mrz 2022, 2022

    3318070106 / 9783318070101

    • Softcover

    Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.

    5-star seller
    Contact seller

    Condition: New

    £ 16.57

    £ 19.22 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Taschenbuch. Condition: Neu. Neuware -Despite an overall decrease in tobacco use, lung cancer (80-85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women worldwide. Annual low-dose CT screening of high-risk individuals has the potential to detect early-stage tumors, which can usually be successfully treated with a combination of surgery, radiotherapy, and chemotherapy and, in some cases, targeted therapy. However, most patients with NSCLC still present with advanced or metastatic disease. For these patients, initial therapy is guided by the tumor's molecular characteristics and patient's performance status. Targeted therapies have significantly improved clinical outcomes and, for some patients with no targetable genetic alterations, immunotherapy has demonstrated significant overall survival benefit. This insightful guide is designed to bring you up to speed with the latest developments and is important reading for all health professionals and medical trainees working in this fast-moving field. Table of Contents: -Prevention and screening -Diagnosis and staging -Surgery -Radiotherapy -Systemic therapy in non-metastatic NSCLC -Systemic therapy in advanced-stage/metastatic disease without a molecular driver -Personalized treatment in advanced NSCLC -Oligometastatic disease and brain metastases 146 pp. Englisch.…

  • Language: English

    Published by Karger, S. Karger Mai 2022, 2022

    3318070106 / 9783318070101

    • Softcover

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    £ 16.57

    £ 29.25 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Taschenbuch. Condition: Neu. Neuware - Despite an overall decrease in tobacco use, lung cancer (80-85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women worldwide. Annual low-dose CT screening of high-risk individuals has the potential to detect early-stage tumors, which can usually be successfully treated with a combination of surgery, radiotherapy, and chemotherapy and, in some cases, targeted therapy. However, most patients with NSCLC still present with advanced or metastatic disease. For these patients, initial therapy is guided by the tumor's molecular characteristics and patient's performance status. Targeted therapies have significantly improved clinical outcomes and, for some patients with no targetable genetic alterations, immunotherapy has demonstrated significant overall survival benefit. This insightful guide is designed to bring you up to speed with the latest developments and is important reading for all health professionals and medical trainees working in this fast-moving field. Table of Contents: -Prevention and screening -Diagnosis and staging -Surgery -Radiotherapy -Systemic therapy in non-metastatic NSCLC -Systemic therapy in advanced-stage/metastatic disease without a molecular driver -Personalized treatment in advanced NSCLC -Oligometastatic disease and brain metastases.…

  • Language: English

    Published by Karger, 2022

    3318070106 / 9783318070101

    • Softcover

    Seller: preigu, Osnabrück, Germanypreigu

    5-star seller
    Contact seller

    Condition: New

    £ 16.57

    £ 58.50 shipping 
    Ships from Germany to U.S.A.

    Quantity: 1 available

    Taschenbuch. Condition: Neu. Fast Facts: Non-Small-Cell Lung Cancer | Mary O'Brien (u. a.) | Taschenbuch | Englisch | 2022 | Karger | EAN 9783318070101 | Verantwortliche Person für die EU: Karger Freiburg, Wilhelmstr. 20a, 79098 Freiburg, orders[at]karger[dot]com | Anbieter: preigu.